A n A ly s i s
Label-free biosensor technology based on dynamic mass redistribution (DMR) of cellular constituents promises to translate GPCR signaling into complex optical 'fingerprints' in real time in living cells. Here we present a strategy to map cellular mechanisms that define label-free responses, and we compare DMR technology with traditional second-messenger assays that are currently the state of the art in GPCR drug discovery. The holistic nature of DMR measurements enabled us to (i) probe GPCR functionality along all four G-protein signaling pathways, something presently beyond reach of most other assay platforms; (ii) dissect complex GPCR signaling patterns even in primary human cells with unprecedented accuracy; (iii) define heterotrimeric G proteins as triggers for the complex optical fingerprints; and (iv) disclose previously undetected features of GPCR behavior. Our results suggest that DMR technology will have a substantial impact on systems biology and systems pharmacology as well as for the discovery of drugs with novel mechanisms.
G protein-coupled receptors (GPCRs) are among the most important drug target classes 1 . For many members of this receptor family, it is now well established that they oscillate among multiple conformations that can be differentially stabilized by ligands, thus permitting access to only a subset of the complete repertoire of receptor behaviors [2] [3] [4] [5] [6] [7] [8] . This phenomenon, also referred to as biased agonism or functional selectivity, has important implications for GPCR-related drug discovery because it raises the possibility to design signaling pathway-specific therapeutics.
Activation of downstream signaling events of GPCRs has been traditionally recorded with assays based on quantification of distinct intracellular second messengers 5, [9] [10] [11] and/or translocation of β-arrestin proteins 5, [12] [13] [14] [15] [16] . It is becoming increasingly apparent, however, that integrated cellular responses-rather than individual components of signaling pathways-need to be analyzed, because different classes of GPCRs typically produce one or more specific second messengers and because GPCRs may engage additional non-G protein effectors [17] [18] [19] [20] [21] . An optical biosensor technology, based on measurement of the cellular process of dynamic mass redistribution, was recently developed to monitor such integrated signaling responses. In DMR technology, polarized light is passed through the bottom of a biosensor microtiter plate containing the cell samples, and a shift in wavelength of reflected light is indicative of redistribution of cellular constituents triggered upon receptor activation (Fig. 1a ) 5, 22, 23 . The wavelength shift may vary in magnitude, direction (positive or negative) and over time depending on how different activated signaling pathways cause various intracellular molecules to relocate.
DMR technology enables GPCR function to be analyzed without labeling. In the assay, receptor activity is measured as an optical trace that represents the generic response of living cells, reminiscent of the holistic responses obtained in tissue or organ bath experiments. Label-free technologies could therefore be decisively advantageous to monitor even complex signaling processes, particularly in primary cells, which are difficult to analyze with traditional biochemical methods and which are difficult to transfect with labeled components of the GPCR signaling cascade for optical studies [23] [24] [25] . It is likely that these obstacles have so far precluded assessment of drug candidates in their native environment.
Although label-free recording of DMR is already being applied in pharmaceutical companies on a more empirical basis to assess feasibility for high-throughput screening or for pharmacological ligand profiling [25] [26] [27] [28] [29] , no in-depth analytical study had been conducted that compared this technology platform with the methods traditionally used in early drug discovery.
Therefore, we applied DMR to monitor signaling of a number of GPCRs from all four coupling classes (G i /G o , G s , G q and G 12 /G 13 ) and compared the receptor's functionality for inducing a whole-cell response with the more classical biochemical approaches to define GPCR signal transduction. An experimental strategy is presented to identify the post-receptor trigger underlying the optical response profiles, thereby allowing optical traces to be precisely assigned to distinct GPCR-mediated signaling pathways. We then take advantage Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements A n A ly s i s of this strategy to explore complex GPCR signaling patterns in both recombinant and primary human cells. Notably, our results provide evidence that simultaneous visualization of signaling pathways by DMR, but not by recording of defined downstream signaling events in single component functional assays, enables unexpected signaling phenomena to be identified, thus implying the need to shift from single-component to system analysis. We suggest that optical recording of DMR represents an enabling technology with substantial impact on both the dissection of complex biological signaling patterns of GPCRs in basic research and the understanding of mechanisms of drug action in GPCR drug discovery.
RESULTS

DMR reports signaling of G i /G o -, G s -and G q -linked receptors
To establish that DMR measures signaling downstream of different G protein classes, CHO cells stably transfected to express the G i /G osensitive muscarinic receptor M 2 , the G q -linked muscarinic receptor M 3 , or the G s -sensitive adrenergic β 2 receptor were challenged with increasing concentrations of their respective agonists, and DMR was recorded as a function of receptor activity. For all three receptors, real-time optical recordings were concentration dependent and varied depending on the primary signaling pathway of each receptor (Fig. 1b-d) . Ligand activity was undetectable in native CHO cells, demonstrating that the DMR traces required the presence of the respective GPCRs (Supplementary Fig. 1 ).
To further establish whether heterotrimeric G proteins are responsible for orchestrating the observed temporal response patterns, we chose to pharmacologically silence the G protein signaling pathways using pertussis toxin (PTX) to block G i /G o signaling, YM-254890 (hereafter referred to as YM) to suppress G q signaling (ref. 30) , and cholera toxin (CTX) to mask G s signaling. Indeed, M 2 receptor traces were completely abrogated by PTX but unaffected by YM and CTX (Fig. 1e) , identifying G i /G o proteins as upstream triggers for this optical fingerprint. On their own, PTX, YM or CTX did not induce a DMR response (Supplementary Fig. 2 ). Furthermore, G protein activation, as reflected by GTPγ S binding assays, was in good agreement with the DMR data ( Fig. 1) , thus supporting the notion that the optical traces resulted from a G i -mediated signaling event. Corresponding observations were made for G s -and G q -DMR assays: the G s signatures of the β 2 receptor were exclusively masked by CTX but not by PTX or YM (Fig. 1f) , and the G q signatures of the M 3 receptor were masked by YM but not by PTX or CTX ( Fig. 1g and Supplementary Fig. 3) . Again, traditional second-messenger assays suggested that optical traces are a consequence of engaging the respective signaling pathways assigned to both receptors (Fig. 1i,j) .
DMR can identify signaling along the G 12 /G 13 pathway Whereas second-messenger assays are well suited to detect activation of G i -, G s -and G q -sensitive receptors, such assays are not yet available to detect G 12 /G 13 signaling, apart from highcontent screening or approaches that assume contribution of these G proteins by recording mostly far removed downstream events 31 . To demonstrate that DMR provides information about signaling through this fourth Gα protein family, we took advantage of the atypical cannabinoid receptor GPR55, which is the only GPCR known to date with exclusive bias toward the G 12 /G 13 pathway 8, 32, 33 . Human embryonic kidney (HEK293) cells were chosen to establish a stable GPR55-expressing clone, because these cells were virtually unresponsive in DMR assays to lysophosphatidylinositol (LPI), currently the most suitable GPR55 agonist [32] [33] [34] ( Supplementary  Fig. 4a ). Of note, wild-type CHO cells responded with robust A n A ly s i s DMR signals to LPI challenge, whereas the same cells did not show any significant LPI effect in traditional second-messenger assays covering the G i , G s and G q pathways and were therefore judged unsuitable for transfection with and functional exploration of GPR55 ( Supplementary Fig. 4b-d ). GPR55-HEK cells displayed concentration-dependent optical traces upon exposure to LPI (Fig. 2a,b) . Notably, GPR55-mediated DMR was insensitive to inhibition of G i , G s or G q signaling by PTX, CTX or YM, but was silenced when cells were pretreated with the pan-G protein activator aluminum fluoride (AlF 4 − ) (Fig. 2c) . This effect could not be explained by a general blunting of cell responsiveness in DMR assays ( Supplementary Fig. 5 ). These data suggest a G-protein origin of the GPR55 trace that is independent of coupling to G i /G o , G s and G q proteins, a conclusion that is further corroborated by the lack of second-messenger production in GPR55-HEK cells (Supplementary Fig. 6 ). Notably, GPR55-HEK cells transfected to coexpress dominant negative G13 (G13dn, G13Q226L,D294N) did not display altered GPR55 cell surface expression ( Supplementary  Fig. 7 ) but did show substantially diminished LPI-induced DMR responses, whereas optical traces elicited by carbachol to stimulate endogenously expressed G q -sensitive muscarinic receptors, as a control, were virtually unaffected ( Fig. 2d-f) . Taken together, these data suggest that DMR is competent to visualize signaling along the G 12 /G 13 pathway and therefore represents a methodology applicable to probe functionality of GPCRs from all four coupling classes, which at present is beyond reach of most GPCR assay platforms.
DMR response profiles are cell type dependent As signaling-dependent relocation of cellular constituents is likely to depend on cellular background, we also examined G i /G o -, G q -and G s -mediated DMR responses in HEK293 cells. The G i -coupled prostaglandin D 2 receptor CRTH2 revealed a signature profile comparable to that observed for the G i -coupled M 2 receptor in CHO cells ( Fig. 3a; compare Fig. 1b) . Similar DMR traces were also obtained when a panel of additional G i /G o -coupled receptors were analyzed ( Supplementary  Fig. 8 ), supporting the notion that optical traces may indeed be suggestive of engagement of particular signaling pathways. However, a positive DMR signal was observed when the G s signaling cascade was activated in HEK cells by the lipid mediator prostaglandin E 1 (PGE 1 ), which acts via the two endogenously expressed G s -linked EP2-EP4 receptors, or by orciprenaline, which stimulates endogenous β 2 receptors ( Fig. 3 and Supplementary Fig. 9) ; this was in contrast to the downward-deflected G s signature in CHO cells (Fig. 1c) . Similar cellular context dependency was also observed when forskolin, a direct adenylyl cyclase activator that bypasses the receptor, was applied. DMR responses of forskolin are essentially superimposable on those induced by stimulation of G s GPCR agonists in both CHO and HEK293 cells (Supplementary Fig. 10 ). Differentiation of signatures with pathway modulators (Fig. 3b-d,g-i) , specific receptor antagonists (data not shown) and second-messenger assays (Fig. 3e,j) confirmed and validated that optical traces for the tested receptors faithfully reflect stimulation of signaling pathways previously assigned to them. Taken together, these disparate DMR measurements suggest that unique differences exist in the spatiotemporal organization of the G s downstream signaling network in these two cell lines.
Holistic DMR recordings uncover signaling promiscuity
The free fatty acid receptor FFA1 has previously been classified as a G q /G 11 sensitive receptor [35] [36] [37] . Stimulating FFA1-HEK cells with the small-molecule agonist TUG424 (ref. 38 ) induced robust DMR responses, distinct in shape from those obtained for G i -and G s -coupled receptors in this cellular background (compare Fig. 4a with Fig. 3a,f) . However, unlike what would be expected for a G qsensitive receptor, FFA1-mediated DMR was only partly sensitive to inhibition by the G q inhibitor YM ( Fig. 4b ; compare black and blue trace), although the same concentration of YM was sufficient to completely silence FFA1 activity in assays quantifying generation of inositol phosphates (IP1 assays), the classical approach to measure functional activity of G q /G 11 -sensitive receptors (Fig. 4c) . Apparently, FFA1 engages signaling pathways in addition to the G q /G 11 pathway in this particular cellular background. Indeed, FFA1 also signals through the G i pathway, as inferred from both the partial PTX sensitivity of the DMR signal ( Fig. 4b ; compare black and gray trace) and the partial inhibition by PTX of ERK1/2 MAP kinase phosphorylation (Supplementary Fig. 11 ). In agreement with a dual G q /G i coupling profile, only the combination of PTX and YM was required and Fig. 4b ; compare black and red trace). Notably, however, G i activity of FFA1 was barely detectable in traditional second-messenger cAMP inhibition assays (Fig. 4d) , which is in good agreement with previous observations 35, 36 . These findings highlight a strength of DMR technology: not only does DMR offer access to high content integrated cellular information, it also provides mechanistic insight if used in conjunction with inhibitors to deconvolute complex signaling pathways.
DMR can analyze GPCR function in human primary cells
Analyzing GPCR-mediated signal transduction in primary human cells-the cell type in which medicines are intended to mediate their therapeutic effect-is highly desirable for GPCR drug candidates. To test whether DMR is sufficiently sensitive to detect GPCR signaling in a native environment, we chose the cAMP-elevating agent PGE 1 as a stimulus, known to affect cell growth and cytokine production of human keratinocytes 39 , and monitored DMR in both immortalized (HaCaT cells) and primary human keratinocytes obtained from six patients who underwent skin surgery. HaCaT and primary human keratinocytes responded with concentration-dependent optical traces reminiscent of those already observed in PGE 1 -treated HEK293 cells ( Fig. 5a,b; compare Fig. 3f) . Indeed, PGE 1 traces in both HaCaT and primary human keratinocytes reflect activation of the two G s -coupled EP2-EP4 receptors because the responses were sensitive to inhibition by a combination of EP2-EP4 antagonists (Fig. 5c,d ), and were invisible following CTX-but not PTX-or YM-treatment (Fig. 5e,f and data not shown). Notably, although cAMP and DMR assays were both sufficiently sensitive to quantify PGE 1 activity in primary human cells, DMR was superior with respect to the quality of the signal window under conditions of low receptor expression (Fig. 5g,h ).
DMR uncovers unknown signaling paradigms
It has been shown that persistent activation of the G s signaling pathway can augment muscarinic M 3 receptor-mediated inositol phosphate production 40 . At first glance, the results reported here might appear to be in good accordance with this earlier report as we detected enhanced muscarinic M 3 receptor signaling in the presence of cAMP-elevating agents such as CTX (Figs. 1g and 6a) and forskolin ( Fig. 6b ; red versus black trace). However, these enhanced M 3 signaling responses in DMR assays were sensitive to pretreatment of the cells with PTX, implying a G i /G o -mediated event ( Fig. 6a,b ; red versus blue trace). In contrast, M 3 DMR was completely insensitive to PTX pretreatment when intracellular cAMP was not elevated before application of the muscarinic agonist ( Fig. 6a,b ; gray versus black trace). These observations indicate that elevated intracellular cAMP-when present before the muscarinic agonist-serves as a stimulus to enable the M 3 receptor to engage an additional signaling pathway. Notably, detection of G i activity under conditions of elevated cAMP can also be accomplished by immunocapture GTPγS binding assays (Fig. 6c) but not by traditional cAMP inhibition assays, in which receptor agonist and forskolin need to be co-applied simultaneously, not sequentially, to obtain measurable cAMP level changes as exemplified for the bona fide G i -linked muscarinic M 2 receptor (Supplementary Fig. 12 ).
DISCUSSION
GPCRs constitute the single largest family of cell surface receptors, attracting great interest as therapeutic targets in all major disease A n A ly s i s areas 1 . Accordingly, assay technologies enabling discovery of novel GPCR ligands are likely to substantially influence the drug discovery process. Recently, label-free technology platforms based on dynamic mass redistribution of intracellular proteins such as the Corning Epic Biosensor (for operating principle see Fig. 1a ) or alteration of electric impedance have emerged for the study of GPCRs 5, [22] [23] [24] [25] 41 . However, no in-depth analytical study to date has thoroughly 'validated' and/or compared the novel DMR technology with the more traditional biochemical and second-messenger assays that have been the mainstay of GPCR drug development. Our results show that DMR technology can capture receptor activation of all four GPCR coupling classes (G i /G o , G s , G q and G 12 /G 13 ), which at present is unachievable by most other technology platforms. DMR technology therefore represents a universal, pathway-unbiased yet pathway-sensitive approach toward investigation of G proteinmediated effects. The ability of the technology to detect signaling A n A ly s i s along the G 12 /G 13 pathway may be of great relevance to future 'GPCR deorphanization' strategies, particularly as receptors previously considered to be non-signaling might exclusively signal through G 12 /G 13 . Although lack of pathway bias is highly advantageous for deorphanization studies, the possibility must be considered that DMR traces, if opposing in direction and possessing identical kinetics, may yield zero signatures and therefore mask activity of biologically relevant molecules. Nevertheless, the use of pathway blockers should uncover such hidden pathway activation. DMR technology and traditional second-messenger assays also diverge greatly in another aspect: DMR displays an overall cellular response, most likely encompassing a variety of cellular events downstream of the GPCR 5, [22] [23] [24] , which is in stark contrast to quantification of defined second messengers that only partially determine the overall response. This likely explains why agonist potencies determined with both methods may, but do not necessarily have to, converge. Indeed, this study revealed that the sensitivity of DMR is at least equal or even superior (Fig. 1i) to that of second-messenger recording for the detection of receptor-dependent, G protein-mediated signaling.
Complexity of optical traces obviously raises the possibility that an unimaginable wealth of intracellular players may be involved in defining the fine details of signature amplitude and duration. It will be exciting to unravel the individual components shaping complex optical response patterns, perhaps using libraries of signaling pathway inhibitors or genome-wide genetic screens with siRNA libraries. Our study does not solve the signature riddle completely, but provides a major mechanistic advance toward understanding the complex optical traces. Namely, heterotrimeric G proteins represent the postreceptor trigger responsible for orchestrating the complex response profiles for the various receptors and cellular backgrounds examined here, which was demonstrated using a combination of toxins and pharmacological pathway inhibitors.
The experimental power of these tools in label-free detection has been shown in this study for many different receptors and various cellular backgrounds, including primary human keratinocytes. Given the emerging successes in directing differentiation of embryonic or pluripotent stem cells to mature cells such as neurons or endothelial cells 42, 43 , label-free DMR detection raises the exciting possibility of expanding studies of drug action mechanisms and even drug screening processes to physiologically relevant cells. Native signaling has already been addressed in publications using label-free DMR detection 25 . All of these reports, however, have involved the analysis of immortalized cell lines 25 , which are much less close to tissue biology than the primary human cells used here.
Our study also demonstrates how the collation of signaling routes within one dynamic, all-encompassing response, and its mechanistic deconvolution with appropriate pharmacological tools, can visualize unexpected signaling phenomena. Identification of an additional signaling pathway for the free fatty acid receptor FFA1 is one such example. In fact, the application of DMR technology to reveal ligand efficacy along the G i pathway is particularly noteworthy because this aspect of FFA1 behavior is hardly detectable in the traditional cAMP inhibition assay (Fig. 4d) . Identification of cAMP as an intracellular stimulus that confers signaling multiplicity onto the muscarinic M 3 receptor is another example. Although M 3 -G i interaction has been inferred indirectly many years ago on the basis of partial PTX sensitivity of M 3 -mediated responses 44, 45 , a defined stimulus for this event has remained elusive so far. It is therefore important to stress that this particular mode of cellular cross-talk has been uncovered because DMR visualizes the summation of individual GPCR signaling routes during a single experiment, and because DMR, in contrast to traditional biochemical assays, does not require pharmacological manipulation of the second-messenger adenylyl cyclase-cAMP pathway to probe G protein (G i ) activity.
In summary, comparative analysis of traditional biochemical methods with the more recently developed DMR technology platform uncovers the experimental power of whole-cell label-free detection. Not only does DMR provide a temporally resolved readout for the summation of receptor-triggered signaling events in recombinant and primary living cells with unprecedented sensitivity and accuracy, but it is this cumulative readout of cellular activity that may disclose further levels of biological complexity in the regulation of signal transduction processes. We therefore anticipate that DMR, as a holistic readout of cell function, will advance systems biology and systems pharmacology and thereby promote the discovery of therapeutics with novel mechanisms.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturebiotechnology/.
Note: Supplementary information is available on the Nature Biotechnology website.
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We thank U. Rick, M. Vasmer-Ehses and T. Kögler for expert technical assistance and Corning Inc. for providing us with the Epic system. This work was supported by the DFG (Deutsche Forschungsgemeinschaft) grants KO 1582/3-1 to E.K., MO 821/2-1 to K.M. and WE 4428/1-1 to J.W. and by the Dr. Hilmer Foundation Figure 6 The muscarinic M 3 receptor adapts to adenylyl cyclase activation with a changed signaling repertoire. (a,b) Set of DMR experiments addressing (a) indirect and (b) direct activation of adenylyl cyclase by cholera toxin (CTX) and forskolin (Fsk), respectively. Acetylcholine (100 μM)-induced DMR traces were measured under control conditions and after pretreatment with pertussis toxin (100 ng/ml; PTX), CTX (100 ng/ml) or Fsk (10 μM) as indicated. Representative data (mean + s.e.m.) from at least three independent experiments. Note that PTX sensitivity emerges only after pretreatment with either CTX or forskolin. (c) GTPγS binding assay on membranes prepared from M 3 -CHO cells. M 3 -CHO cells were grown to confluence and were left untreated or were pretreated with CTX (20 h, 100 ng/ml) before membrane preparation. GTPγS incorporation was determined in the absence and presence of 1 mM acetylcholine followed by immunoenrichment of G i proteins with an antiserum to the C-terminal region common to G i proteins, as described in the Online Methods (mean + s.e.m., n = 3). P values <0.05 were considered statistically significant according to one-way analysis of variance (ANOVA) with Bonferroni's correction for multiple comparisons, as appropriate. 
